United States : NuVasive Announces Regulatory Approval Of Reline Posterior Fixation Technology In Japan.
Jason M. Hannon, Executive Vice President, International, said, We are very pleased to receive regulatory approval of Reline in Japan as it moves us toward launching our industry-leading iGA technology in our largest and fastest growing international market. Japans exceptional growth over the last three years demonstrates the clear benefit of focusing our market penetration efforts around our complete procedural offerings such as XLIF, which we are now replicating in additional key international markets.
With the pending launch of iGA in Japan, we expect to drive robust adoption of this technology to address proper spinal alignment and drive improved long-term patient outcomes. In doing so, we aim to mirror the positive impact iGA has already had in driving our strong lumbar momentum in the U.S. over the past several quarters. The continued success of our Precept posterior fixation system, augmented now by the approval of Reline, supports our confidence in fueling more than 30% growth in our Japanese market for the year as we look to approach the $40 million revenue mark for 2016 a key contributor to our core NuVasive international growth of approximately 20% this year, Mr. Hannon concluded.
Japan is the worlds second largest spine market and NuVasives largest market outside of the U.S. The Company first entered the Japanese market in 2013 leading with the highly differentiated benefits of its minimally invasive XLIF surgical approach. More than three years later, NuVasive has trained hundreds of surgeons on the XLIF technology and thousands of patients have been treated with the NuVasives comprehensive portfolio of procedurally integrated solutions for the spine, providing reproducible and clinically proven surgical outcomes.
Reline Posterior Fixation Technology
The Reline portfolio is the evolution of posterior fixation technology within the iGA platform that can be utilized in open surgeries or with the Companys Maximum Access Surgery, or MAS, procedural solutions. The Reline launch will begin later this year in Japan and continue into 2017.
Whether preserving or restoring spinal alignment, the seamless and versatile design of Reline provides one system to address even the most difficult pathologies for both deformity and degenerative applications. The competitive benefits of Reline include surgical efficiency, operative reliability and procedural versatility. Its Universal Open and MAS solutions were created to help deliver an enhanced surgical experience with fully compatible Open and MAS instrumentation, seamless integration with the Companys NVM5 neuromonitoring technology, and streamlined rod insertion facilitated by the Bendini Rod Bending system.
The iGA Advantage
NuVasive believes iGA is an industry-leading platform that marks a significant advancement in the historical approach to spine surgery by integrating procedural technology and tools into one platform to help address proper alignment. The suite of proprietary, procedurally-based technologies that comprise iGA are designed to enhance clinical outcomes by increasing the predictability of achieving global alignment in spinal procedures. The iGA platform is seamlessly integrated across the surgical workflow and is designed to help the surgeon:
CALCULATE alignment parameters with preoperative planning tools; CORRECT the anterior and posterior columns with comprehensive implant solutions using real-time intraoperative assessment; and CONFIRM the restoration and preservation of global sagittal alignment postoperatively.
[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 11, 2016|
|Previous Article:||United States : I.D. Systems Wins $1.4 Million Contract From New Intermodal Container Customer.|
|Next Article:||United Kingdom,United States : IPC Thought Leader to Present at the World Exchange Congress.|